Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

55.97 -3.20 (-5.41%)
Official Closing Price Updated: 7:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Reasonable Valuation
Globus Medical (NYSE:GMED) offers strong growth, solid profitability, and reasonable valuation, making it an attractive pick for investors seeking affordable growth in the healthcare sector. 
Via Chartmill
Price Over Earnings Overview: Globus Medical
Via Benzinga
2 Reasons to Watch GMED and 1 to Stay Cautious
Shareholders of Globus Medical would probably like to forget the past six months even happened. The stock dropped 28.9% and now trades at $58.14. This was partly due to its softer quarterly results and... 
Via StockStory
Is the Market Bullish or Bearish on Globus Medical?
Via Benzinga
1 Cash-Producing Stock with Solid Fundamentals and 2 to Be Wary Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
A Look Into Globus Medical Inc's Price Over Earnings
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
What Does the Market Think About Globus Medical?
Via Benzinga
Medical Devices & Supplies - Specialty Stocks Q1 Recap: Benchmarking Globus Medical (NYSE:GMED)
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. 
Via StockStory
GMED Q1 Earnings Call: Integration Challenges, New Acquisition, and Market Uncertainties Shape Outlook
Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s... 
Via StockStory
Topics Economy
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Technical Breakout Potential
Globus Medical (NYSE:GMED) shows strong growth fundamentals and a technical setup suggesting a potential breakout. The stock combines revenue growth, profitability, and a favorable chart pattern. 
Via Chartmill
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock with Reasonable Valuation
GLOBUS MEDICAL (NYSE:GMED) is a strong growth stock with reasonable valuation, solid profitability, and a healthy balance sheet, making it an attractive option for investors seeking growth at a fair... 
Via Chartmill
2 Growth Stocks to Add to Your Roster and 1 to Brush Off
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID... 
Via StockStory
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Via Benzinga
Assessing Globus Medical: Insights From 4 Financial Analysts
Via Benzinga
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock at a Reasonable Price
GLOBUS MEDICAL (NYSE:GMED) offers strong growth potential at a reasonable valuation, backed by solid financial health. A closer look at its fundamentals suggests it could be a compelling pick for... 
Via Chartmill
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
A Glimpse Into The Expert Outlook On Globus Medical Through 6 Analysts
Via Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Globus Medical (NYSE:GMED) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops 17.1%
Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s... 
Via StockStory
Earnings To Watch: Globus Medical (GMED) Reports Q1 Results Tomorrow
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
GLOBUS MEDICAL INC - A (NYSE:GMED)
Globus Medical (NYSE:GMED) shows strong growth potential with solid fundamentals and a promising technical setup, making it a stock to watch for investors seeking high-growth opportunities. 
Via Chartmill
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling return of 3.4%. However, the stock is beating the S&P 500’s 5.2% decline... 
Via StockStory
Topics Stocks
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable.
Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued. 
Via Chartmill
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.